$MDGL 3 SEC Filings

Filed On	Filing
18 Aug 2026	Form 3: Reed John C, Director No securities owned
20 Jan 2026	Form 3: Thakkar Rita, Chief Accounting Officer No securities owned
05 Aug 2025	Form 3: Brennan Daniel J., Director No securities owned
24 Apr 2025	Form 3: Soergel David, Chief Medical Officer No securities owned
12 Mar 2025	Form 3: Fouse Jacqualyn A, Director No securities owned
15 Aug 2024	Form 3: Kelley Shannon T, General Counsel Holds 2,767 shares of Common Stock
21 Mar 2024	Form 3: Dier Mardi, SVP and CFO Holds 8,875 shares of Common Stock
22 Nov 2023	Form 3: Huntsman Carole, Chief Commercial Officer No securities owned
13 Sep 2023	Form 3: Sibold William John, Director No securities owned
20 Jun 2023	Form 3: Cheong Raymond, Director No securities owned
20 Jun 2023	Form 3: Baker Bros. Advisors Lp, Director and 5 others Holds 148,821 shares of Common Stock
04 Aug 2021	Form 3: Waltermire Robert E., Senior VP, Chief Pharma Dev. No securities owned
19 May 2021	Form 3: Howarth Alex G., Chief Financial Officer No securities owned
02 Apr 2020	Form 3: Sukhija Remy, SVP and Chief Comm'l Officer
01 Jul 2019	Form 3: Daly James M, Director
08 May 2019	Form 3: Lynch Brian Joseph, SVP and General Counsel Holds 530 shares of Common Stock
21 Nov 2016	Form 3: Levy Richard S, Director Holds 0 shares of No securities are beneficially owned
29 Jul 2016	Form 3: Bate Kenneth, Director No securities owned
29 Jul 2016	Form 3: Milligan David V, Director No securities owned
26 Jul 2016	Form 3: Bay City Capital Llc, Director and 3 others Holds 5,538,474 shares of Common Stock

Comments